SEMAX / SELANK

Selank, a synthetic analogue of tuftsin, is a notable short peptide with remarkable properties, particularly in the realms of anxiety modulation and cognitive enhancement. Developed in Russia, Selank stands out for its anxiolytic effects, making it a subject of interest in the treatment of generalized anxiety disorder. As a derivative of Tuftsin, Selank shares similarities in its ability to modulate various physiological factors, including IL-6, T helper cells, monoamine neurotransmitters, and brain-derived neurotropic factor (BDNF). What sets Selank apart is its structural modification, with an additional four amino acids enhancing its metabolic stability and half-life.

Semax, a synthetic derivative of adrenocorticotrophic hormone, has emerged as a multifaceted peptide with potential benefits across various physiological domains. Originating from Russia, Semax has been investigated for its diverse therapeutic properties. Research suggests that Semax may play a role in enhancing immune function, providing neuroprotection, and promoting cardiovascular well-being. Its potential applications extend to pain management and blood clotting regulation, making it a peptide of interest in various medical contexts.